Background illustration for clinical trials search

Paid Clinical Trials Newport

Discover 489 paid clinical trials in Newport, Rhode Island. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2
New

Oral VK2735 for Weight Management Phase 3 (SUNRISE 1)

for
Weight Loss
Location: East Greenwich RI, Rochester NY, Morehead City NC,
Sponsor: Viking Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT07868835

Phase 3, Recruiting
New

Oral VK2735 for Weight Management in Adults With Type 2 Diabetes Mellitus Phase 3 (SUNRISE 2)

for
Weight Loss
Location: East Greenwich RI, Binghamton NY, Charleston SC,
Sponsor: Viking Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT07868939

Phase 3, Recruiting

Phase 3 Study of Denifanstat in Participants With Moderate to Severe Acne (AURORA)

for
Acne Vulgaris
Location: East Greenwich RI, Portsmouth NH, Robbinsville NJ,
Sponsor: Sagimet Biosciences Inc.

Sex: All

Age: 12+

Code: NCT07863193

Phase 3, Recruiting

Study of Revumenib in Combination With Intensive Chemotherapy in Newly Diagnosed Acute Myeloid Leukemia (AML) With a NPM1 Mutation

for
Acute Myeloid Leukemias
Location: Providence RI, Farmington CT, Morristown NJ, Montreal,
Sponsor: Syndax Pharmaceuticals

Sex: All

Age: 12+

Code: NCT07211958

Phase 3, Recruiting

HP-211 Safety and Proof of Concept Dose Ranging Study in Patients With Type 2 Diabetes

for
Type 2 Diabetes
Location: East Greenwich RI, Burke VA, Midlothian VA, Canton OH,
Sponsor: Housey Healthcare ULC

Sex: All

Age: 18+

Code: NCT07546929

Phase 2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Fibromyalgia Response With Esreboxetine Evaluated Using a Randomized Withdrawal Research Design

for
Fibromyalgia
Location: Cranston RI, North Dartmouth MA, Boston MA,
Sponsor: Axsome Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT07398417

Phase 3, Recruiting

Phase 3 Study of the Efficacy, Safety, and Clinical Outcomes of Pemvidutide in MASH

for
Metabolic Dysfunction-Associated Steatohepatitis (MASH)
Location: East Greenwich RI, New Bedford MA, Fresno CA, Orange CA,
Sponsor: Altimmune, Inc.

Sex: All

Age: 18 - 70+

Code: NCT07795164

Phase 3, Recruiting

Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer

for
Metastatic Colorectal Cancer (CRC)
Location: Providence RI, Norwich CT, Newton MA, Boston MA,
Sponsor: Summit Therapeutics

Sex: All

Age: 18+

Code: NCT07228832

Phase 3, Recruiting

Randomized Study in Children and Adolescents With Migraine: Acute Treatment

for
Pediatric Migraine
Location: East Greenwich RI, Cromwell CT, Commack NY, Stamford CT,
Sponsor: Pfizer

Sex: All

Age: 6 - 17

Code: NCT04649242

Phase 3, Recruiting

Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine

for
Acute Treatment of Migraine
Location: East Greenwich RI, Cromwell CT, Commack NY, Stamford CT,
Sponsor: Pfizer

Sex: All

Age: 6 - 17

Code: NCT04743141

Phase 3, Recruiting

A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)

for
Metabolic Dysfunction-Associated Steatotic Liver Disease (MASH) / Nonalcoholic Steatohepatitis (NASH) With Fibrosis,
Location: East Greenwich RI, Burlington MA, Carmel NY,
Sponsor: Hoffmann-La Roche

Sex: All

Age: 18 - 70+

Code: NCT06318169

Phase 3, Recruiting

A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH

for
Metabolic Dysfunction-Associated Steatohepatitis (MASH) / Nonalcoholic Steatohepatitis (NASH) With Compensated Cirrhosis,
Location: East Greenwich RI, Framingham MA, Burlington MA,
Sponsor: Hoffmann-La Roche

Sex: All

Age: 18 - 70+

Code: NCT06419374

Phase 3, Recruiting

Acoustic Cluster Therapy (ACT) With Chemotherapy for the Treatment of Locally Advanced Pancreatic Cancer

for
Locally Advanced Pancreatic Adenocarcinoma
Location: Providence RI, Boston MA, Philadelphia PA,
Sponsor: EXACT Therapeutics AS

Sex: All

Age: 18+

Code: NCT06850623

Phase 2, Recruiting

Screening Study for KIT D816V Mutated Mast Cell Disease in Select Populations

for
Clonal Mast Cell Disease, KIT D816V Mutation,
Location: Warwick RI, New York NY, Glenn Dale MD, Pittsburgh PA,
Sponsor: Blueprint Medicines Corporation

Sex: All

Age: 18+

Code: NCT07143669

Recruiting

This Study is a Non-interventional Disease Registry of Adolescent and Adult Patients With Atopic Dermatitis Who Initiate or Switch Any Systemic Treatment

for
Atopic Dermatitis
Location: Warwick RI, Portsmouth NH, Falls Church VA,
Sponsor: Sanofi

Sex: All

Age: 12+

Code: NCT07290803

Recruiting

Rhode Island - Statewide Postpartum Hypertension Remote Surveillance

for
Hypertension in Pregnancy, Postpartum Preeclampsia,
Location: Warwick RI, Providence RI, Woonsocket RI
Sponsor: Women and Infants Hospital of Rhode Island

Sex: Female

Age: 18 - 60

Code: NCT06842875

Recruiting

The THOR IDE Study

for
Peripheral Artery Disease, Peripheral Artery Stenosis,
Location: Fall River MA, Providence RI, New York NY, Portland ME,
Sponsor: Philips Clinical & Medical Affairs Global

Sex: All

Age: 18+

Code: NCT05916950

Recruiting

Study of the Long-Term Safety and Outcomes of Treating Pulmonary Embolism With the Indigo Aspiration System

for
Pulmonary Embolism
Location: Fall River MA, Providence RI, Boston MA, Roslyn NY,
Sponsor: Penumbra Inc.

Sex: All

Age: 18+

Code: NCT04798261

Recruiting

Bucillamine Phase 2 Trial in Patients With Cystinuria

for
Cystinuria
Location: Warwick RI, Boston MA, New York NY, Madison WI,
Sponsor: Revive Therapeutics, Ltd.

Sex: All

Age: 18 - 70+

Code: NCT02942420

Phase 2, Recruiting

OPI-NXYDLD-303 Safety and Efficacy of Phentolamine Ophthalmic Solution in Keratorefractive Surgery Participants With Decreased Mesopic Visual Acuity

for
Vision Loss Night, Vision Disorders
Location: Warwick RI, Woburn MA, Cranberry Township PA, Garner NC,
Sponsor: Opus Genetics, Inc

Sex: All

Age: 18+

Code: NCT07140783

Phase 3, Recruiting